JMS Co

JMS Co Enterprise Value

The Enterprise Value (EV) of JMS Co (7702.T) as of Nov 2, 2026 is 31.06 B JPY. In the previous year, Enterprise Value (EV) was 29.81 B JPY — a change of 4.18% (higher).

Enterprise Value

31.06 BJPY

YoY

4.18%

Last updated:

Enterprise Value (EV) of JMS Co is 2026 31.06 B JPY. Enterprise Value (EV) of JMS Co was 2025 29.81 B JPY. It decreases by 4.18% higher compared to the previous year.

The JMS Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
22.47 B JPY
Jan 1, 2020
23.21 B JPY
Jan 1, 2021
23.05 B JPY
Jan 1, 2022
22.68 B JPY
Jan 1, 2023
24.19 B JPY
Jan 1, 2024
27.39 B JPY
Jan 1, 2025
29.81 B JPY
Jan 1, 2026
31.06 B JPY
The JMS Co Enterprise Value history
YEAREnterprise ValueYoY
31.06 BJPY+4.18%
29.81 BJPY+8.85%
27.39 BJPY+13.21%
24.19 BJPY+6.69%
22.68 BJPY-1.63%
23.05 BJPY-0.66%
23.21 BJPY+3.28%
22.47 BJPY-2.84%
23.12 BJPY+3.76%
22.29 BJPY+4.25%
21.38 BJPY+13.50%
18.83 BJPY+7.91%
17.45 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Enterprise Value (EV) of JMS Co is 31.06 B JPY in 2026.

Enterprise Value (EV) of JMS Co changed from 29.81 B JPY to 31.06 B JPY, representing a 4.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) JMS Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s JPY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' JPY varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s JMS Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — JMS Co

All Key Metrics — JMS Co